Andrew Poklepovic, MD

School of Medicine, Virginia Commonwealth University
Richmond, Virginia, United States

Disclosure information not submitted.

Presentation(s):

• Paper 21 - PHASE 1 RESULTS OF THE WEE1 INHIBITOR, AZENOSERTIB, IN COMBINATION WITH GEMCITABINE IN ADULT AND PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY OSTEOSARCOMA

  Thursday, November 14, 2024
  1:45 PM – 3:15 PM PST

• Paper 84 - PLANNED ANALYSIS OF THE PIVOTAL IGNYTE-ESO TRIAL OF LETE-CEL IN PATIENTS WITH SYNOVIAL SARCOMA OR MYXOID/ROUND CELL LIPOSARCOMA.

  Saturday, November 16, 2024
  10:30 AM – 12:00 PM PST